Conclusion
Health system resources may be triaged accordingly based on clinical
features associated with prompt recovery in patients hospitalized for
COVID-19. Concurrent antibacterial therapy needs to be judiciously
prescribed to minimize the selection of antimicrobial resistance and
untoward adverse effects (e.g. C. difficile diarrhea).